Middle East & Africa Genetic Testing Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
The Middle East & Africa Genetic Testing Services Market size was valued at US$ 87.99 Mn in 2023 and is projected to reach US$ 236.91 Mn by 2031, growing at a CAGR of 13.2% during 2023 - 2031.
Report Coverage
- Service Type: Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Genetic Testing, Others
- Disease: Cancer, Cardiovascular Diseases, Metabolic Diseases, Other Diseases
- Service Provider: Hospital-Based Laboratories, Diagnostic Laboratories, Others
US$ 87.99 Mn
Market size in 2023
US$ 236.91 Mn
Market Size by 2031
13.2%
CAGR, 2023 - 2031
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Genetic Testing Services Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Genetic Testing Services Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Genetic Testing Services Market Regional Analysis
6.2 Middle East & Africa Genetic Testing Services Market Revenue 2021-2031 (US$ Million)
6.3 Middle East & Africa Genetic Testing Services Market Forecast Analysis
7. Middle East & Africa Genetic Testing Services Market Analysis – by Service Type
7.1 Predictive Testing
- 7.1.1 Overview
- 7.1.2 Predictive Testing: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Carrier Testing
- 7.2.1 Overview
- 7.2.2 Carrier Testing: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Prenatal Testing
- 7.3.1 Overview
- 7.3.2 Prenatal Testing: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Newborn Screening
- 7.4.1 Overview
- 7.4.2 Newborn Screening: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Diagnostic Genetic Testing
- 7.5.1 Overview
- 7.5.2 Diagnostic Genetic Testing: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Middle East & Africa Genetic Testing Services Market Analysis – by Disease
8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Cancer: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Cardiovascular Diseases
- 8.2.1 Overview
- 8.2.2 Cardiovascular Diseases: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Metabolic Diseases
- 8.3.1 Overview
- 8.3.2 Metabolic Diseases: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Other Diseases
- 8.4.1 Overview
- 8.4.2 Other Diseases: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Middle East & Africa Genetic Testing Services Market Analysis – by Service Provider
9.1 Hospital-Based Laboratories
- 9.1.1 Overview
- 9.1.2 Hospital-Based Laboratories: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Diagnostic Laboratories: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Middle East & Africa Genetic Testing Services Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa- 10.2.1 Middle East & Africa Genetic Testing Services Market Breakdown, by Key Country, 2024 and 2031 (%)
- 10.2.1.1 Middle East & Africa Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 Saudi Arabia: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 Saudi Arabia: Middle East & Africa Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.1.2 Saudi Arabia: Middle East & Africa Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.1.3 Saudi Arabia: Middle East & Africa Genetic Testing Services Market Breakdown, by Service Provider
- 10.2.1.2 UAE: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 UAE: Middle East & Africa Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.2.2 UAE: Middle East & Africa Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.2.3 UAE: Middle East & Africa Genetic Testing Services Market Breakdown, by Service Provider
- 10.2.1.3 South Africa: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 South Africa: Middle East & Africa Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.3.2 South Africa: Middle East & Africa Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.3.3 South Africa: Middle East & Africa Genetic Testing Services Market Breakdown, by Service Provider
- 10.2.1.4 Rest of Middle East and Africa: Middle East & Africa Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Genetic Testing Services Market Breakdown, by Service Type
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Genetic Testing Services Market Breakdown, by Disease
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Genetic Testing Services Market Breakdown, by Service Provider
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Eurofins Scientific SE
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Exact Sciences Corp
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Laboratory Corp of America Holdings
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 23andMe Holding Co
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Ambry Genetics Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Quest Diagnostics Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Illumina Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 F. Hoffmann-La Roche Ltd
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 NeoGenomics Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Centogene NV
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Ancestry Genomics Inc
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Gene By Gene Ltd
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 SIVOTEC BioInformatics LLC
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 Progenesis
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 Fulgent Genetics, Inc
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments
13.16 VERITAS INTERCONTINENTAL
- 13.16.1 Key Facts
- 13.16.2 Business Description
- 13.16.3 Products and Services
- 13.16.4 Financial Overview
- 13.16.5 SWOT Analysis
- 13.16.6 Key Developments
13.17 GeneDx, LLC
- 13.17.1 Key Facts
- 13.17.2 Business Description
- 13.17.3 Products and Services
- 13.17.4 Financial Overview
- 13.17.5 SWOT Analysis
- 13.17.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full M Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
